Published in N Engl J Med on April 10, 1975
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol (2010) 2.26
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A (1990) 2.12
Detection of hepatitis A antigen by immunofluorescence. Infect Immun (1977) 2.00
Hepatitis E virus: identification of type-common epitopes. J Virol (1991) 1.95
Molecular approaches to the identification of unculturable infectious agents. Emerg Infect Dis (1996) 1.81
Role of chronic hepatitis in development of thalassaemic liver disease. Arch Dis Child (1976) 1.80
The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol (2013) 1.69
The history of the "natural history" of hepatitis C (1968-2009). Liver Int (2009) 1.63
Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci U S A (1994) 1.60
The hazards of blood transfusion in historical perspective. Blood (2008) 1.54
Membranous replication factories induced by plus-strand RNA viruses. Viruses (2014) 1.40
Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun (1983) 1.35
25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end. Nat Rev Immunol (2013) 1.35
Quantitation of antibody to hepatitis A antigen by immune electron microscopy. Infect Immun (1976) 1.24
Antibody to hepatitis C virus in risk groups in Canada. Can J Infect Dis (1992) 1.20
Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev (2003) 1.13
Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients. Br Med J (1978) 1.13
The pathology of viral hepatitis types A and B in chimpanzees. A comparison. Am J Pathol (1976) 1.13
Epidemiology and natural history of hepatitis C virus infection. World J Gastroenterol (2014) 1.11
Hepatocellular carcinoma in the world and the middle East. Middle East J Dig Dis (2010) 1.07
Hepatitis type A, B, and non-A non-B in fulminant hepatitis. Gut (1980) 1.03
Management of chronic hepatitis C. Postgrad Med J (2005) 1.03
Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results. J Clin Microbiol (2011) 1.03
Commercial factor VIII associated hepatitis, 1974-75, in the United Kingdom: a retrospective survey. J Hyg (Lond) (1978) 1.02
Detection of hepatitis A virus and antibody by solid-phase radioimmunoassay and enzyme-linked immunosorbent assay with monoclonal antibodies. J Clin Microbiol (1985) 0.98
Renal failure in otherwise uncomplicated acute viral hepatitis. Br Med J (1978) 0.97
Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays. Asian J Transfus Sci (2014) 0.95
Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev (2014) 0.93
New animal models for hepatitis C viral infection and pathogenesis studies. World J Gastroenterol (2007) 0.92
Progress in clinical virology--1960 to 1980: a recollection of twenty years. Yale J Biol Med (1980) 0.89
Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model. J Clin Pathol (1996) 0.87
Serological markers for hepatitis types A and B among U.S. Arym soldiers, Germany. Am J Public Health (1979) 0.87
Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Mediterr J Hematol Infect Dis (2009) 0.85
Detection and transmission in chimpanzees of hepatitis B virus-related agents formerly designated "non-A, non-B" hepatitis. Proc Natl Acad Sci U S A (1982) 0.85
Cyclophilin inhibitors as a novel HCV therapy. Viruses (2010) 0.82
Hepatitis C virus: propagation, quantification, and storage. Curr Protoc Microbiol (2010) 0.82
Non-A, non-B hepatitis. Yale J Biol Med (1976) 0.82
Mortality and morbidity among military personnel and civilians during the 1930s and World War II from transmission of hepatitis during yellow fever vaccination: systematic review. Am J Public Health (2013) 0.81
Antiviral therapy. Yale J Biol Med (1978) 0.81
Hepatitis C Infection in the Elderly. Dig Dis Sci (2015) 0.80
Viral hepatitis: past and future of HBV and HDV. Cold Spring Harb Perspect Med (2015) 0.80
Hepatitis non-A, non-B. Can Med Assoc J (1980) 0.79
Viral hepatitis. West J Med (1978) 0.79
HCV animal models: a journey of more than 30 years. Viruses (2009) 0.78
Patterns of progression: unpredictability and risk of decompensated cirrhosis. Dig Dis Sci (1996) 0.78
Hepatitis A. Yale J Biol Med (1976) 0.77
Hepatitis C virus NS3 inhibitors: current and future perspectives. Biomed Res Int (2013) 0.77
Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection. Eur J Clin Microbiol Infect Dis (2013) 0.77
Progression of hepatitis non-A, non-B to chronic active hepatitis: a histological follow-up of two cases. J Clin Pathol (1979) 0.77
Recent advances in the identification of hepatitis viruses. Postgrad Med J (1977) 0.76
Experimental models of hepatitis B and C - new insights and progress. Nat Rev Gastroenterol Hepatol (2016) 0.76
An insight into the molecular characteristics of hepatitis C virus for clinicians. Saudi Med J (2016) 0.76
Non-A, non-B hepatitis: dead ends or new horizons? Br Med J (Clin Res Ed) (1987) 0.75
Proteomic approaches to analyzing hepatitis C virus biology. Proteomics (2015) 0.75
Promising developments in viral hepatitis. West J Med (1975) 0.75
Viral hepatitis. Gut (1991) 0.75
Hepatitis viruses: characterization and diagnostic techniques. Yale J Biol Med (1980) 0.75
Parenterally acquired non-A non-B hepatitis ten years on: advances in diagnosis and therapy. Postgrad Med J (1990) 0.75
The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C. Dig Dis Sci (2015) 0.75
Hepatology. Postgrad Med J (1991) 0.75
Prevalence of antibodies to hepatitis C virus in patients with various types of liver diseases. Korean J Intern Med (1992) 0.75
Bioinformatic Analysis of Codon Usage and Phylogenetic Relationships in Different Genotypes of the Hepatitis C Virus. Hepat Mon (2016) 0.75
Strategies for Human Tumor Virus Discoveries: From Microscopic Observation to Digital Transcriptome Subtraction. Front Microbiol (2016) 0.75
Etiological characterization of hepatitis B surface antigen-negative hepatitis among adult patients in Athens, Greece. J Clin Microbiol (1980) 0.75
Hepatitis C Virus and Antiviral Drug Resistance. Gut Liver (2016) 0.75
Non-A non-B hepatitis. Br Med J (1978) 0.75
Editorial: The several viruses of post-transfusion hepatitis. Br Med J (1975) 0.75
Clinical efficacy and cost effectiveness of intraoperative cell salvage in pelvic trauma surgery. Ann R Coll Surg Engl (2013) 0.75
Hepatitis in the 1980s. Am J Public Health (1979) 0.75
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
DNA polymerase associated with human hepatitis B antigen. J Virol (1973) 10.71
Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol (1972) 9.12
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92
Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol (1993) 8.47
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med (1989) 8.10
Enzyme-linked immunosorbent assay (ELISA) for detection of human reovirus-like agent of infantile gastroenteritis. Lancet (1977) 7.84
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science (1997) 7.53
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol (1969) 6.85
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol (1993) 6.36
A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J Hyg (Lond) (1966) 6.23
Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A (1997) 6.09
A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A (1997) 6.07
Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94
Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science (1973) 5.82
Color test for the measurement of antibody to T-strain mycoplasmas. J Bacteriol (1966) 5.61
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis (1995) 5.53
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 5.51
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science (2000) 5.49
Reoviruslike agent in stools: association with infantile diarrhea and development of serologic tests. Science (1974) 5.32
Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. J Virol (2000) 5.26
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A (1980) 5.12
An African primate lentivirus (SIVsm) closely related to HIV-2. Nature (1989) 5.03
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A (1996) 4.82
Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med (1977) 4.80
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med (1991) 4.79
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci U S A (2001) 4.62
Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol (1996) 4.59
Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43
A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A (1993) 4.30
Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 4.28
Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med (1991) 4.24
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol (1993) 4.13
Comparison of human and animal rotavirus strains by gel electrophoresis of viral RNA. Virology (1978) 4.08
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. Virology (1999) 4.04
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol (2002) 3.83
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80
Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73
Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A (1992) 3.72
Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1989) 3.67
Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A (2004) 3.57
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56
New complement-fixation test for the human reovirus-like agent of infantile gastroenteritis. Nebraska calf diarrhea virus used as antigen. Lancet (1975) 3.56
Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A (1992) 3.55
A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. J Immunol (1976) 3.53
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet (1976) 3.38
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol (1993) 3.37
At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A (1993) 3.37
Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet (1980) 3.31
Australia antigen: large-scale purification from human serum and biochemical studies of its proteins. J Virol (1971) 3.28
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. Virology (1987) 3.22
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science (1984) 3.20
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol (1989) 3.19
Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun (1981) 3.18
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis (1974) 3.10
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol (1994) 3.06
ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis (1993) 3.06
Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children. J Clin Microbiol (1981) 3.05
Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (1984) 3.03
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med (1992) 3.01
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med (1990) 2.99